Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review

Fernandes, Lara Vilar; Paiva, Alexandre Elias Gomes; Silva, Ana Clara Borges; Castro, Isabela Coelho de; Santiago, Andrezza Fernanda; Oliveira, Erick P. de; Porto, Laura Cristina Jardim

doi:10.1007/s40520-021-01951-7

Cited by 55 publications

(35 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[ 5 ], cross-sectionally and longitudinally, and a recent systematic review by Fernandes et al . [ 40 ] found that the prevalence of sarcopenia by EWGSOP2 was considerably lower than EWGSOP1 . In all the studies aforementioned, EWGSOP2 was used with lower LMS cut-off and, as a result, a lower prevalence of sarcopenia was reported.…”

Section: Discussionmentioning

confidence: 99%

European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) criteria or slowness: which is the best predictor of mortality risk in older adults?

et al. 2022

View full text Add to dashboard Cite

Objectives to analyse the accuracy of grip strength and gait speed in identifying mortality; to compare the association between mortality and sarcopenia defined by the EWGSOP1 and EWGSOP2 using the best cut-off found in the present study and those recommended in the literature and to test whether slowness is better than these two definitions to identify the risk of death in older adults. Methods a longitudinal study was conducted involving 6,182 individuals aged 60 or older who participated in the English Longitudinal Study of Ageing. Sarcopenia was defined based on the EWGSOP1 and EWGSOP2 using different cut-off for low muscle strength (LMS). Mortality was analysed in a 14-year follow-up. Results compared with the LMS definitions in the literature (<32, <30, <27 and < 26 kg for men; <21, <20 and < 16 kg for women), the cut-off of <36 kg for men (sensitivity = 58.59%, specificity = 72.96%, area under the curve [AUC] = 0.66) and < 23 kg for women (sensitivity = 68.90%, specificity = 59.03%, AUC = 0.64) as well as a low gait speed (LGS) ≤0.8 m/s (sensitivity = 53.72%, specificity = 74.02%, AUC = 0.64) demonstrated the best accuracy for mortality. Using the cut-off found in the present study, probable sarcopenia [HR = 1.30 (95%CI: 1.16–1.46)], sarcopenia [HR = 1.48 (95%CI: 1.24–1.78)] and severe sarcopenia [HR = 1.78 (95%CI: 1.49–2.12)] according to EWGSOP2 were better predictors of mortality risk than EWGSOP1. LGS ≤0.8 m/s was a better mortality risk predictor only when LMS was defined by low cut-off. Conclusions using LMS <36 kg for men and < 23 kg for women and LGS ≤ 0.8 m/s, EWGSOP2 was the best predictor for mortality risk in older adults.

show abstract

Section: Discussionmentioning

confidence: 99%

European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) criteria or slowness: which is the best predictor of mortality risk in older adults?

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Moreover, the EWGSOP operational definition offered cut-off points for muscle strength that corresponded to those of the weakness item in the Fried criteria. Very recent studies have shown that the EWGSOP2 diagnostic criteria detect lower prevalences than EWGSOP [38], i.e., the 2010 original version presents greater sensitivity [39].…”

Section: Discussionmentioning

confidence: 99%

Prevalence and Clinical Conditions Related to Sarcopaenia among Older Persons Living in the Community

Blanco-Reina

Ocaña-Riola

Ariza-Zafra

et al. 2022

JCM

View full text Add to dashboard Cite

(1) Background: In health care and in society at large, sarcopaenia is a disorder of major importance that can lead to disability and other negative health-related events. Our study aim is to determine the prevalence of sarcopaenia among older people attended in primary care and to analyse the factors associated with this age-related clinical condition; (2) Methods: A multicentre cross-sectional study was conducted of 333 community-dwelling Spanish adults aged 65 years or more. Sociodemographic, clinical, functional, anthropometric, and pharmacological data were collected. Sarcopaenia was defined following European Working Group on Sarcopaenia in Older People (EWGSOP) criteria; (3) Results: Sarcopaenia was present in 20.4% of the study sample, and to a severe degree in 6%. The intensity of the association between sarcopaenia and frailty was weak-moderate (Cramer V = 0.45). According to the multinomial logistic regression model performed, sarcopaenia was positively associated with age and with the presence of psychopathology (OR = 2.72; 95% CI = 1.30–5.70) and was inversely correlated with body mass index (OR = 0.73, 95% CI = 0.67–0.80; (4) Conclusions: Sarcopaenia commonly affects community-dwelling older persons and may be associated with age, body mass index, and psychopathology. The latter factor may be modifiable or treatable and is therefore a possible target for intervention.

show abstract

“…Muscle atrophy is one of the most visible hallmarks of skeletal muscle aging [2][3][4]. Starting from the beginning of the 4th decade, muscle mass decreases by approximately 0.5% every year [5].…”

Section: Aging and Sarcopenia: Convergences And Divergencesmentioning

confidence: 99%

Beyond the current knowledge on sarcopenia: new insight on neuromuscular factors

2022

View full text Add to dashboard Cite

Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review

Cited by 55 publications

References 25 publications

European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) criteria or slowness: which is the best predictor of mortality risk in older adults?

European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) criteria or slowness: which is the best predictor of mortality risk in older adults?

Prevalence and Clinical Conditions Related to Sarcopaenia among Older Persons Living in the Community

Beyond the current knowledge on sarcopenia: new insight on neuromuscular factors

Contact Info

Product

Resources

About